Literature DB >> 7285347

A micro-method for the rapid ultracentrifugal separation of human plasma high density lipoprotein subfractions, HDL2 and HDL3.

J Eyre, F Hammett, N E Miller.   

Abstract

Currently available ultracentrifugal procedures for separating the two major density subfractions of HDL (HDL2 and HDL3) are time-consuming and expensive, and require relatively large volumes of plasma. In order to overcome these problems, a rapid and simple procedure, requiring only 0.5 ml plasma, has been developed. After precipitation of apoprotein B-containing lipoproteins with heparin and MnCl2, 120 microliters of the supernatant is adjusted to a density of 1.125 g/ml with aqueous NaCl-NaBr, and centrifuged for 3.5 h at 160000 x g in an air-driven bench-top ultracentrifuge (Beckman Airfuge). The HDL2 is then removed in a tube-slicer, constructed to permit six Airfuge tubes to be sliced simultaneously, and the cholesterol content assayed by a cholesterol oxidase procedure. The method provides an alternative to the recently described heparin/MnCl2/dextran sulphate double-precipitation procedure, with the advantage of permitting quantitative recovery of intact HDL2.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7285347     DOI: 10.1016/0009-8981(81)90395-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  High-density lipoprotein subfractions in normolipidemic individuals without clinical atherosclerosis lipoprotein subfractions in an adult population.

Authors:  Fabio L Sodré; Vera S Castanho; Lucia N Castilho; Silvia de Barros-Mazon; Eliana C de Faria
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

2.  Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer.

Authors:  V Michalaki; G Koutroulis; K Syrigos; C Piperi; A Kalofoutis
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

3.  Associations of alcohol consumption with plasma high density lipoprotein cholesterol and its major subfractions: the Caerphilly and Speedwell Collaborative Heart Disease Studies.

Authors:  N E Miller; C H Bolton; T M Hayes; D Bainton; J W Yarnell; I A Baker; P M Sweetnam
Journal:  J Epidemiol Community Health       Date:  1988-09       Impact factor: 3.710

4.  Evaluation of the rapid micromethod for ultracentrifugal separation of labeled plasma lipoproteins.

Authors:  R B Shireman; D Williams
Journal:  Lipids       Date:  1983-09       Impact factor: 1.880

5.  Protective modulation of carotid atherosclerosis in hyperalphalipoproteinemic individuals.

Authors:  F D Santiago; R T Nakamura; D Kaplan; E C de Faria
Journal:  Int J Cardiovasc Imaging       Date:  2009-10-30       Impact factor: 2.357

6.  Plasma and lipoprotein lipids and apolipoproteins AI, AII and B in patients with chronic airflow limitation.

Authors:  C H Bolton; E Mulloy; J Harvey; L G Downs; M Hartog
Journal:  J R Soc Med       Date:  1989-02       Impact factor: 5.344

7.  Prevalence of ischaemic heart disease and associations with serum lipoproteins in subjects aged 45 to 64 years. The Speedwell study.

Authors:  D Bainton; C J Burns-Cox; P C Elwood; B Lewis; N E Miller; K Morgan; P M Sweetnam
Journal:  Br Heart J       Date:  1982-05

8.  The I405V and Taq1B polymorphisms of the CETP gene differentially affect sub-clinical carotid atherosclerosis.

Authors:  Eliane Soler Parra; Natália Baratella Panzoldo; Denise Kaplan; Helena Coutinho Franco de Oliveira; José Ernesto dos Santos; Luiz Sérgio Fernandes de Carvalho; Andrei Carvalho Sposito; Magnus Gidlund; Ruy Tsutomu Nakamura; Vanessa Helena de Souza Zago; Edna Regina Nakandakare; Eder Carlos Rocha Quintão; Eliana Cotta de Faria
Journal:  Lipids Health Dis       Date:  2012-10-05       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.